SEC Form 4 · accession 0001104659-18-070832
BioXcel Therapeutics, Inc. · BTAI
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Krishnan Nandabalan
Director · 10% Owner
Period of report
Nov 29, 2018
Accepted (ET)
Nov 30, 2018 · 4:17 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001720893
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Nov 29, 2018 | P | 1,000 | $4.915 | A | 1,000 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1By Krishnan Nandabalan and Suganthi Balasubramanian JTWROS